A PiRNA Utilizes HILI and HIWI2 Mediated Pathway to Down-regulate Ferritin Heavy Chain 1 MRNA in Human Somatic Cells
Overview
Affiliations
The piwi interacting RNAs (piRNAs) are small non-coding RNAs that specifically bind to the PIWI proteins, a functional requirement. The piRNAs regulate germline development, transposons control, and gene expression. However, piRNA-mediated post-transcriptional gene regulation in human somatic cells is not well understood. We discovered a human piRNA (piR-FTH1) which has a complementary sequence in the ferritin heavy chain 1 (Fth1) mRNA. We demonstrated that expression of piR-FTH1 and Fth1 are inversely correlated in the tested tumor cell lines. We found that piR-FTH1 negatively regulates the Fth1 expression at post-transcriptional level in triple negative breast cancer (TNBC) cells. Additionally, we confirmed that transfected piR-FTH1 knocks down the Fth1 mRNA via the HIWI2 and HILI mediated mechanism. piR-FTH1 mediated Fth1 repression also increased doxorubicin sensitivity by a remarkable 20-fold in TNBC cells. Since the current piRNA-mediated knockdowns of target mRNA are mostly reported in germ line cells, piRNA-mediated post-transcriptional gene regulation in somatic cells is rather unique in its application and mechanistically uses an alternative pathway to siRNA and miRNA. This work begins to lay the groundwork with a broader impact on treatment of various diseases that are linked to elevated levels of specific mRNAs which have a piRNA target.
Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.
Benacka R, Szaboova D, Gulasova Z, Hertelyova Z Int J Mol Sci. 2025; 26(1.
PMID: 39795985 PMC: 11719911. DOI: 10.3390/ijms26010127.
Somatic piRNA and PIWI-mediated post-transcriptional gene regulation in stem cells and disease.
Patel M, Jiang Y, Kakumani P Front Cell Dev Biol. 2024; 12:1495035.
PMID: 39717847 PMC: 11663942. DOI: 10.3389/fcell.2024.1495035.
HEPPAR1 and PIWIL2 as Panel Markers for Hepatocellular Carcinoma.
Hammad G, Magdy M, Aboushousha T, Abdelraouf A, Mamdouh S Asian Pac J Cancer Prev. 2024; 25(6):2123-2131.
PMID: 38918675 PMC: 11382836. DOI: 10.31557/APJCP.2024.25.6.2123.
piR-1919609 Is an Ideal Potential Target for Reversing Platinum Resistance in Ovarian Cancer.
Yan Y, Tian D, Zhao B, Li Z, Huang Z, Li K Technol Cancer Res Treat. 2024; 23:15330338241249692.
PMID: 38706262 PMC: 11072069. DOI: 10.1177/15330338241249692.
Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells.
Garcia-Borja E, Siegl F, Mateu R, Slaby O, Sedo A, Busek P Biomark Res. 2024; 12(1):15.
PMID: 38303021 PMC: 10836005. DOI: 10.1186/s40364-024-00563-3.